CENTOGENE N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4408 USD | -4.38% |
|
-4.38% | -63.27% |
| Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
| Mar. 19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
Chart calendar Centogene N.V.
7483cbae72560558fdaa.0ykBEPUoWnndelLuMbUNYvbLssaKI1IepaYWCySH4pw.gxlZIsFvFg6kQjebacBlE5-F-pblaiMrl9RvUmu11tC-fG1onHovO783Ew~8211bdbc1856cd0252087f4d089a2b2f
Upcoming events on Centogene N.V.
Past events on Centogene N.V.
| Today | Q4 2023 Earnings Release (Projected) |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-09-07 05:00 pm | Q2 2023 Earnings Release |
| 2023-08-29 11:00 am | BioValley Basel Conference |
| 2023-08-12 | Brazilian Medical Genetics Congress |
| 2023-06-30 08:00 am | Annual General Meeting |
| 2023-05-22 | World Orphan Drug Congress |
| 2023-05-16 06:25 pm | Q4 2022 Earnings Release |
| 2023-05-15 | BIONNALE Conference |
| 2023-05-10 11:00 am | The State of Precision Medicine Conference |
| 2023-05-06 | International Society for Pharmacoeconomics and Outcomes Research Conference |
| 2023-05-04 | Human Genome Meeting |
| 2023-04-24 | Digital Medical Expertise & Applications Conference |
| 2023-04-21 | American Academy of Neurology Meeting |
| 2023-04-17 | Pharma Europe Conference |
| 2023-03-29 06:00 am | Research & Innovation Meeting - Rosalind Franklin Room |
| 2023-03-27 | Pharma USA Conference |
| 2023-03-21 | Asian Inherited Metabolic Diseases Congress |
| 2023-03-19 | Gene Therapy for Rare Disorders Summit |
| 2023-03-17 12:30 pm | American College of Medical Genetics & Genomics Meeting - Abstract No : #P576 |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 40,5 | 48,8 48,6 0.34% | 128 101 27.37% | 190 175 8.23% | 47,5 47,4 0.18% | 48,6 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | -5,69 -5,41 -5.2% | 1,08 -14,4 107.51% | -16,7 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -18,7 -16,9 -10.6% | -19,7 -24,9 20.77% | -46,0 -48,9 5.93% | -36,8 -40,8 9.76% | -42,6 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -20,7 -19,0 -9.21% | -21,1 -26,9 21.71% | -46,9 -49,9 6.02% | -38,6 -43,9 12.18% | -48,6 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | -20,9 -19,1 -9.15% | -21,4 -27,1 21.16% | -46,9 -51,4 8.77% | -31,8 -44,1 27.84% | -48,6 |
|
EPS EUR | Released Forecast Spread | -40,0 | -1,30 -2,74 52.55% | -1,02 -1,32 22.87% | -2,06 -2,30 10.43% | -1,19 -1,66 28.31% | -1,60 |
| Announcement Date | 28/03/19 | 23/04/20 | 15/04/21 | 30/03/22 | 16/05/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 51,9 41,4 25.37% | 30,2 25,0 20.58% | 42,9 28,4 50.86% | 10,3 29,0 -64.33% | 11,2 11,6 -3.58% | 12,1 | 13,5 | 13,3 | 11,5 | 12,5 | 14,0 | 14,5 | 15,0 | |
|
EBITDA Million EUR | Released Forecast Spread | -2,07 -2,98 30.76% | -12,7 -6,65 -90.56% | -2,65 | |||||||||||
|
EBIT Million EUR | Released Forecast Spread | -7,68 -4,98 -54.17% | -21,3 -10,8 -98.37% | -12,4 -15,3 18.99% | -10,8 | -9,34 | -8,77 | -10,8 | -10,5 | -10,1 | -10,0 | -9,90 | |||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -7,90 -5,08 -55.51% | -21,6 -10,9 -97.95% | -12,5 -15,5 19.41% | -11,7 | -10,2 | -10,2 | -12,2 | -11,9 | -11,5 | -11,4 | -11,3 | |||
|
Net income Million EUR | Released Forecast Spread | -8,22 -5,11 -60.88% | -21,6 -11,0 -96.94% | -12,3 -16,9 27.08% | -6,48 -11,6 43.96% | -10,3 -8,23 -25.67% | -8,17 | -10,2 | -10,2 | -24,5 | -12,2 | -11,9 | -11,5 | -11,4 | -11,3 |
|
EPS EUR | Released Forecast Spread | -0,37 -0,24 -57.45% | -0,96 -0,49 -95.92% | -0,51 -0,74 31.39% | -0,28 -0,50 44% | -0,38 -0,35 -8.57% | -0,35 | -0,37 | -0,37 | -0,88 | -0,44 | -0,34 | -0,27 | -0,27 | -0,24 |
| Announcement Date | 07/09/21 | 24/11/21 | 30/03/22 | 15/07/22 | 22/12/22 | - | - | - | 07/09/23 | - | - | - | - | - |
More events
Past sector events for Centogene N.V.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CNTG Stock
- Calendar Centogene N.V.
